Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Eisai, Immvira, Impact, Kelun-Biotech, Mabwell, Tramscenta.

Biopharmas in Asia-Pacific raising money in public or private financings: Kazia, OTR Therapeutics.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Ascentage, BMS, Vanda.

Biopharma happenings, including deals and partnerships, and other news in brief: Guard, Innovent, Mural, Takeda, Xoma.

Clinical updates, including data readouts and publications: Amneal, Amylyx, Biogen, Cantargia, Cervomed, CG, Galimedix, Impact, Oric, Praxis, Rapport, Stoke, Transcenta, Zhittya.

Biopharmas raising money in public or private financings, including: Capricor, Immatics, Kala, OTR, Protara.

New hires and promotions in the biopharma industry, including: Jubilant, K36.

New hires and promotions in the med-tech industry, including: Bruker, Oxford Nanopore Technologies, Zeiss.

Med-tech firms raising money in public or private financings, including: Aethlon Medical.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neuropace.